SCHEMBL903731

SCHEMBL903731

COc1ccc2c(c1)OC(C)(C)c1c-2n(C)c2ccc(OC)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
MAPT P10636 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NPSR1 Q6W5P4 2/20 0.40
APAF1 O14727 1/20 0.40
PABPC1 P11940 1/20 0.40
PKM P14618 1/20 0.40
IDO1 P14902 1/20 0.40
MAPK1 P28482 1/20 0.40
RAB9A P51151 1/20 0.40
MCL1 Q07820 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NTRK1 P04629 2/20 0.39
BCHE P06276 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903641 0.82 CNR2 (0.38)
SCHEMBL1985565 0.74 MAPT (0.43) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL19978096 0.73 ALDH1A1 (0.51) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL903658 0.70 MAPKAPK2 (0.49) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL11047658 0.68 ALDH1A1 (0.81) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL13514904 0.66 HTT (0.41) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL1990533 0.66 MAPT (0.52) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL15497467 0.65 MAPT (0.34) ALDH1A1MAPTKDM4EHPGDMEN1
SCHEMBL18215374 0.65 GPR55 (0.57) GPR55
SCHEMBL12601843 0.64 KDM4E (0.47) ALDH1A1MAPTKDM4EHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012040924-A1 FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed
WO-2012041227-A1 TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed